GLE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.592350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.175400E-01
Normal-vs-Stage2
1.374600E-01
Normal-vs-Stage3
3.283800E-02
Normal-vs-Stage4
9.226200E-01
Stage1-vs-Stage2
4.078000E-01
Stage1-vs-Stage3
1.933640E-02
Stage1-vs-Stage4
6.622800E-01
Stage2-vs-Stage3
1.339820E-02
Stage2-vs-Stage4
4.779200E-01
Stage3-vs-Stage4
8.199700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.758400E-01
Normal-vs-AfricanAmerican
2.140000E-01
Normal-vs-Asian
1.945950E-01
Caucasian-vs-AfricanAmerican
9.543800E-01
Caucasian-vs-Asian
6.391200E-01
AfricanAmerican-vs-Asian
7.889200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.615000E-01
Normal-vs-Female
1.746380E-01
Male-vs-Female
8.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.560400E-01
Normal-vs-Age(41-60Yrs)
3.890600E-01
Normal-vs-Age(61-80Yrs)
1.030430E-01
Normal-vs-Age(81-100Yrs)
1.342210E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.368200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.837800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.882200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.118370E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.332000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.776400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.293600E-02
Normal-vs-Daily Drinker
2.941600E-01
Normal-vs-Weekly Drinker
9.711900E-02
Normal-vs-Occasional Drinker
3.417600E-01
Normal-vs-Social Drinker
6.864200E-01
Non Drinker-vs-Daily Drinker
1.043610E-01
Non Drinker-vs-Weekly Drinker
3.954800E-01
Non Drinker-vs-Occasional Drinker
7.898200E-02
Non Drinker-vs-Social Drinker
7.580200E-03
Daily Drinker-vs-Weekly Drinker
5.010400E-01
Daily Drinker-vs-Occasional Drinker
8.424600E-01
Daily Drinker-vs-Social Drinker
2.338400E-01
Weekly Drinker-vs-Occasional Drinker
3.872600E-01
Weekly Drinker-vs-Social Drinker
6.780300E-02
Occasional Drinker-vs-Social Drinker
3.289000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.947600E-01
Normal-vs-Grade 2
8.363400E-01
Normal-vs-Grade 3
8.333600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.471600E-01
Grade 1-vs-Grade 3
3.856600E-01
Grade 1-vs-Grade 4
8.947600E-01
Grade 2-vs-Grade 3
9.500400E-01
Grade 2-vs-Grade 4
8.363400E-01
Grade 3-vs-Grade 4
8.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.116040E-01
Normal-vs-NonDiabetic
1.675190E-01
Diabetic-vs-NonDiabetic
4.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.944000E-01
Normal-vs-NoPancreatitis
1.367580E-01
Pancreatitis-vs-NoPancreatitis
3.093400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.889400E-01
Normal-vs-N1
1.335820E-01
N0-vs-N1
2.701400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.829800E-01
Normal-vs-TP53-NonMutant
3.502600E-01
TP53-Mutant-vs-TP53-NonMutant
2.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
